Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sixian Yu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Materials Horizons|August 19, 2025
<i>In situ</i> SERS and <i>in situ</i> Raman: deciphering interfacial phenomena and processesJingyi Wei, Sixian Yu, Tianxiang Zhou, et al.
Journal of Colloid and Interface Science|April 23, 2026
Unlocking new crossing field: In situ surface-enhanced Raman spectroscopy analyzing the alternating current catalytic process and phenomenon for molecular degradationJingyi Wei, Junxi Huang, Sixian Yu, et al.
European Journal of Medicinal Chemistry|August 12, 2023
Design and optimization of selective and potent CDK9 inhibitors with flavonoid scaffold for the treatment of acute myeloid leukemiaTizhi Wu, Bin Yu, Weihong Gong, et al.
European Journal of Medicinal Chemistry|September 6, 2023
Discovery of novel flavonoid-based CDK9 degraders for prostate cancer treatment via a PROTAC strategyTizhi Wu, Zhiming Zhang, Guangyue Gong, et al.
Journal of Medicinal Chemistry|October 23, 2023
Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung CancerTizhi Wu, Bin Yu, Yifan Xu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Materials Horizons|August 19, 2025
<i>In situ</i> SERS and <i>in situ</i> Raman: deciphering interfacial phenomena and processesJingyi Wei, Sixian Yu, Tianxiang Zhou, et al.
Journal of Colloid and Interface Science|April 23, 2026
Unlocking new crossing field: In situ surface-enhanced Raman spectroscopy analyzing the alternating current catalytic process and phenomenon for molecular degradationJingyi Wei, Junxi Huang, Sixian Yu, et al.
European Journal of Medicinal Chemistry|August 12, 2023
Design and optimization of selective and potent CDK9 inhibitors with flavonoid scaffold for the treatment of acute myeloid leukemiaTizhi Wu, Bin Yu, Weihong Gong, et al.
European Journal of Medicinal Chemistry|September 6, 2023
Discovery of novel flavonoid-based CDK9 degraders for prostate cancer treatment via a PROTAC strategyTizhi Wu, Zhiming Zhang, Guangyue Gong, et al.
Journal of Medicinal Chemistry|October 23, 2023
Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung CancerTizhi Wu, Bin Yu, Yifan Xu, et al.
Pageof 1